World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 12 December 2020
Main ID:  NCT02239523
Date of registration: 10/09/2014
Prospective Registration: Yes
Primary sponsor: Shaare Zedek Medical Center
Public title: Effectiveness or Orthopedic Intervention in Osteoporosis Management After a Fracture of the Hip With Cost-Benefit Analysis
Scientific title: Management Strategies by an Orthopedic Department to Improve the Evaluation and Treatment of Osteoporosis.
Date of first enrolment: February 21, 2017
Target sample size: 200
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT02239523
Study type:  Interventional
Study design:  Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Single (Participant).  
Phase:  N/A
Countries of recruitment
Israel
Contacts
Name:     Gershon Zinger, MD MS
Address: 
Telephone:
Email:
Affiliation:  Shaare Zedek Medical Center, Jerusalem Israel
Key inclusion & exclusion criteria

Inclusion Criteria:

- All patients over age 50 with fragility fracture defined as a fall from standing or
walking position

Exclusion Criteria:

- Patients with metastatic cancer

- Known metabolic bone disease

- End-of-life care

- Inability to provide consent

- Known MRSA carriers

- Fractures of the trochanter alone, shaft or peri-prosthetic fractures



Age minimum: 50 Years
Age maximum: 120 Years
Gender: All
Health Condition(s) or Problem(s) studied
Osteoporotic Fracture
Intervention(s)
Procedure: Intervention Group
Procedure: Letter Group
Primary Outcome(s)
Percentage of patients with osteoporosis that are appropriately treated [Time Frame: Determination of proper treatment will be made at 4 months after the fracture.]
Secondary Outcome(s)
Percentage of patients who undergo DEXA scan. [Time Frame: Evaluation will be made 4 months after the initial fracture event.]
Secondary ID(s)
201497CTIL
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history